Free Access
| Issue |
J Extra Corpor Technol
Volume 44, Number 4, December 2012
|
|
|---|---|---|
| Page(s) | 186 - 193 | |
| DOI | https://doi.org/10.1051/ject/201244186 | |
| Published online | 15 December 2012 | |
- Elliot M. Minimizing the bypass circuit: A rational step in the development of paediatric perfusion. Perfusion. 1993;8:81–86. [CrossRef] [PubMed] [Google Scholar]
- Itoh I, Pouard SS. Pediatric perfusion in Japan: 2010 practice survey. Perfusion. 2012;27:72–77. [CrossRef] [PubMed] [Google Scholar]
- Charrière J, Pélissié M, Verd C, et al. Survey: Retrospective survey of monitoring/safety devices and incidents of cardiopulmonary bypass for cardiac surgery in France. J Extra Corpor Technol. 2007;39:142–157. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Groom R, Hill A, Bechara F, et al. Pediatric perfusion survey. Proc Am Acad CV Perf. 1990;11:78–84. [Google Scholar]
- Groom R, Hill A, Kurusz M. Pediatric perfusion practice in North America; an update. Perfusion. 1995;10:393–401. [CrossRef] [PubMed] [Google Scholar]
- Cecere G, Groom R, Forest R. A 10-year review of pediatric perfusion practice in North America. Perfusion. 2002;17:83–89. [CrossRef] [PubMed] [Google Scholar]
- Groom R, Froebe S, Martin J, et al. Update on pediatric perfusion practice in North America: 2005 survey. J Extra Corpor Technol. 2005;37:343–350. [Google Scholar]
- Matte GS, Del Nido PJ. History and use of Del Nido cardioplegia solution at Boston Children’s Hospital. Ind J Extra Corpor Technol. 2012;22:7–12. [Google Scholar]
- Jensen E, Andreasson S, Bengtsson A, et al. Changes in hemostasis during pediatric heart surgery: Impact of a biocompatible heparincoated perfusion system. Ann Thorac Surg. 2004;77:962–967. [CrossRef] [Google Scholar]
- Jensen E, Andreasson S, Bengtsson A, et al. Influence of two different perfusion systems on inflammatory response in pediatric heart surgery. Ann Thorac Surg. 2003;75:919–925. [CrossRef] [Google Scholar]
- Lindholm L, Westerberg M, Bengtsson A, Ekroth R, Jensen E, Jeppsson A. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients. Ann Thorac Surg. 2004;78:2131–2138. [CrossRef] [Google Scholar]
- Atkins BZ, Danielson DS, Fitzpatrick CM, et al. Modified ultrafiltration attenuates pulmonary-derived inflammatory mediators in response to cardiopulmonary bypass. Interact Cardiovasc Thorac Surg. 2010;11:599–603. [CrossRef] [PubMed] [Google Scholar]
- Preston TJ, Gomez D, Olshove VF, Phillips A. Galantowicz clinical gaseous microemboli assessment of an oxygenator with integral arterial filter in the pediatric population. J Extra Corpor Technol. 2009;41:226–230. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Rodgers E. Diffusion of Innovations. 4th ed. New York, NY: The Free Press; 1995:7–31. [Google Scholar]
- Stammers A, Mejak B, Rauch E, Vang S, Viessman T. Factors affecting perfusionists’ decisions on equipment utilization: Results of a United States survey. J Extra Corpor Technol. 2000;32:4–10. [Google Scholar]
- Liu J, Feng Z, Zhao J, Li B, Long C. The myocardial protection of HTK cardioplegic solution on the long-term ischemic period in pediatric heart surgery. ASAIO J. 2008;54:470–473. [CrossRef] [PubMed] [Google Scholar]
- O’Brien J, Howlett S, Burton H, O’Blenes S, Litz D, Friesen C. Pediatric cardioplegia strategy results in enhanced calcium metabolism and lower serum troponin T. Ann Thorac Surg. 2009;87:1517–1523. [CrossRef] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.